[modern Approaches to Perioperative Therapy for Lung Cancer: "pro" and "contra" from the Perspective of Evidence-based Medicine].

@article{TerOvanesov2015modernAT,
  title={[modern Approaches to Perioperative Therapy for Lung Cancer: "pro" and "contra" from the Perspective of Evidence-based Medicine].},
  author={Michail Ter-Ovanesov and O E Fatuev and A A Aksarin and G A Baksiyan and Adrian Levitsky and E E Lesnidze and M Yu Kukosh},
  journal={Voprosy onkologii},
  year={2015},
  volume={61 3},
  pages={499-506}
}
Patients with resectable non-small cell lung cancer have a chance to reach a 5-year survival rates ranging from 70% or more for stage IA and 20% for stage IIIA. These figures have remained stable for the past 20 years. Moreover, the inability to improve long-term outcomes is generally determined by a fatal disease progression due to the emergence of distant… CONTINUE READING